Halozyme Therapeutics, Inc. 2025 Q1 - Results - Earnings Call ...
Halozyme Therapeutics, Inc. 2024 Q1 - Results - Earnings Call ...
Halozyme Therapeutics, Inc. 2018 Q1 - Results - Earnings Call Slides ...
Halozyme Therapeutics, Inc. 2022 Q4 - Results - Earnings Call ...
Halozyme Therapeutics, Inc. 2025 Q3 - Results - Earnings Call ...
Halozyme Therapeutics, Inc. 2023 Q3 - Results - Earnings Call ...
Braze, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:BRZE ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2026 Earnings Call ...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2026 Earnings Call ...
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2026 Earnings Call Transcript ...
Halozyme Therapeutics - Tremendous Q1 results - 35% growth, ahead of ...
[HALO stock] Halozyme Therapeutics Q1 2021 Earnings Call (5/10/21 ...
Halozyme Therapeutics, Inc. - AnnualReports.com
Halozyme Therapeutics, Inc. (HALO) - Stock Analysis | PortfoliosLab
Earnings Update: Halozyme Therapeutics, Inc. (NASDAQ:HALO) Just ...
Halozyme Therapeutics: Q1 Earnings Reveal A Bigger And Deeper Moat ...
Research Analysts Offer Predictions for HALO FY2025 Earnings - American ...
Halozyme Therapeutics (NASDAQ:HALO) Reports Bullish Q3 CY2025 - The ...
FinancialContent - Halozyme Therapeutics (NASDAQ:HALO) Surprises With ...
Breaking Down Halozyme Therapeutics, Inc. (HALO): Key Insights for ...
Halozyme Therapeutics, Inc. 2009 Investor Day Presentation | PDF ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Receives $62.70 Average ...
Halozyme Therapeutics Q1 2026 earnings preview
Halozyme Therapeutics, Inc. | Statista
Halozyme Therapeutics 2026 Company Profile: Stock Performance ...
Halozyme Therapeutics (HALO): Buy, Sell, or Hold Post Q3 Earnings ...
Halozyme Therapeutics, Inc. revenue 2024| Statista
Halozyme Therapeutics, Inc. operating profit 2024| Statista
Halozyme Therapeutics, Inc. Stock — HALO Overview — Roic AI
Halozyme, Inc. on LinkedIn: Halozyme to Report Second Quarter 2024 ...
Halozyme Therapeutics, Inc. total equity 2024| Statista
Halozyme Therapeutics Q1 2025 Earnings: A Catalyst-Fueled Surge in ...
Halozyme to Report Third Quarter 2024 Financial and Operating Results ...
Halozyme outlines ENHANZE royalties exceeding $1B in 2026 while ...
Halozyme Therapeutics - Crunchbase Company Profile & Funding
DYN Q1 2026 Earnings Report on 5/11/2026
NTLA Q1 2026 Earnings Report on 5/11/2026
Halozyme (HALO) Q4 2025 Earnings Call Transcript | The Motley Fool
TNYA Q1 2026 Earnings Report on 5/6/2026
ALGS Q1 2026 Earnings Report on 5/7/2026
GANX Q1 2026 Earnings Report on 5/11/2026
TTRX Q1 2026 Earnings Report on 5/11/2026
NMRA Q1 2026 Earnings Report on 5/7/2026
TENX Q1 2026 Earnings Report on 5/12/2026
Halozyme Therapeutics Inc (HALO) Reports Strong Year-Over-Year Growth ...
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Combines Strong Growth Momentum ...
Halozyme Therapeutics Inc (NASDAQ:HALO) Demonstrates Strong Growth and ...
Halozyme Therapeutics Inc (NASDAQ:HALO) Embodies Affordable Growth with ...
Benchmark Sees More Upside for Halozyme Therapeutics (HALO), Hikes ...
University of California, San Francisco (UCSF) To Study Halozyme ...
HALOZYME THERAPEUTICS INC (NASDAQ:HALO), a strong growth stock, setting ...
Halozyme Therapeutics Inc (NASDAQ:HALO) Passes Minervini Trend Template ...
Halozyme Therapeutics Inc Earnings Whispers
Halozyme Therapeutics Increases 2025 Financial Projections Following ...
Halozyme Therapeutics Stock: A Reasonable Value In An Overvalued Market ...
HALOZYME THERAPEUTICS INC (NASDAQ:HALO): A GARP Stock with Strong ...
Halozyme Therapeutics: Pharma With Growing Royalty Revenue, Product ...
Halozyme Therapeutics (HALO): Navigating Regulatory Crosscurrents to ...
Yesterday, we hosted an Investor Conference Call during which we ...
Halozyme Therapeutics’ ENHANZE Platform: A Catalyst for Sustained ...
Halozyme Therapeutics Launches $1.3 Billion Convertible Notes Offering ...
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) is a candidate for high growth ...
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Technical Analysis observations ...
Halozyme Therapeutics Inc (NASDAQ:HALO) Shows Strong Growth and ...
Looking for growth without the hefty price tag? Consider HALOZYME ...
Halozyme Therapeutics (NASDAQ:HALO): A Prime GARP Stock with Strong ...
Halozyme Therapeutics: Steady Growth In A Challenged Market (NASDAQ ...
Halozyme Therapeutics (HALO) | Finance information
Halozyme Therapeutics (HALO) Stock Price & Overview
Halozyme: How This Small Biotech Is Getting Under Your Skin | Investor ...
Halozyme Therapeutics Inc's SVP, Chief Technical Officer Michael
Halozyme Therapeutics (NASDAQ:HALO) Surprises With Q4 CY2025 Sales
Halozyme Therapeutics (HALO): Buy, Sell, or Hold Post Q3 Earnings?
Halozyme Therapeutics Stock: Chugging Along (NASDAQ:HALO) | Seeking Alpha
Halozyme Therapeutics (HALO) Downgraded Amid Medicare Negotiatio
Halozyme Therapeutics Inc (HALO): This is also good.
Piper Sandler Upgrades Halozyme Therapeutics (HALO) | Nasdaq
$ 100 invested on 3 12 04 in stock or on 2 29 04 in index including ...
Should You Buy Halozyme Therapeutics (HALO) Ahead of Earnings?
Halozyme Therapeutics (HALO) Stock Price, News & Analysis
Exhibit 99.1
Can Halozyme’s Robust Q3 Turn Gains Into Long-term Success?
